Accuracy of in vivo neuroreceptor quantification by PET and review of steady-state, transient, double injection, and equilibrium models.

The accuracy of in vivo dopamine D2 receptor quantification by positron emission tomography (PET) was determined for several models by means of singular-value decomposition, and some of the model assumptions were reviewed. These include steady-state, transient, double injection, and equilibrium approaches. All four modes are augmented by including a realistic kinetic interaction of the radioligand with the striatal serotonin S2 receptor. When a set of parameters derived specifically with reference to the equilibrium model was applied, it was found that a reversible radioligand used in conjunction with the equilibrium model permits accurate quantification. However, an assumption of the equilibrium model-that equilibrium is achieved during the time of measurement-is shown to be unsupported by the published experimental data. These results indicate that the equilibrium approach can provide an alternative to the kinetic approaches, but that additional experimental evidence is required to demonstrate the validity of the equilibrium assumption.

[1]  O. Inoue,et al.  Visualization of specific binding sites of benzodiazepine in human brain. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  G. Sedvall,et al.  Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.

[3]  C. D. Arnett,et al.  A direct comparison of the brain uptake and plasma clearance of N-[11C]methylspiroperidol and [18F]N-methylspiroperidol in baboon using PET. , 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[4]  C. Lawson,et al.  Solving least squares problems , 1976, Classics in applied mathematics.

[5]  B R Zeeberg,et al.  Analysis of three- and four-compartment models for in vivo radioligand-neuroreceptor interaction. , 1987, Bulletin of mathematical biology.

[6]  R. Reba,et al.  The characteristics of I-125 4-IQNB and H-3 QNB in vivo and in vitro. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  Paul O. Scheibe,et al.  Identifiability Analysis of an In Vivo Receptor-Binding Radiopharmacokinetic System , 1985, IEEE Transactions on Biomedical Engineering.

[8]  S O Ogren,et al.  Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. , 1985, Biochemical pharmacology.

[9]  Henry N. Wagner,et al.  Kinetics of binding to opiate receptors in vivo predicted from in vitro parameters , 1984, Brain Research.

[10]  J M Links,et al.  3H-3-N-methylspiperone labels D2 dopamine receptors in basal ganglia and S2 serotonin receptors in cerebral cortex , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  M E Phelps,et al.  Neuroreceptor Assay with Positron Emission Tomography: Equilibrium versus Dynamic Approaches , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  K A Frey,et al.  Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Lanczos Applied Analysis , 1961 .

[14]  P. Seeman,et al.  Dopamine receptors in brain and periphery , 1987, Neurochemistry International.

[15]  D Comar,et al.  Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography. , 1985, European journal of pharmacology.

[16]  J M Links,et al.  Quantification of Neuroreceptors in the Living Human Brain. II. Inhibition Studies of Receptor Density and Affinity , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  B. Zeeberg,et al.  Quantification of Human Caudate D2 Dopamine Receptor Density with Positron Emission Tomography: A Review of the Model , 1987, IEEE Transactions on Medical Imaging.

[18]  T Greitz,et al.  Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Michael V. Green,et al.  Theoretical Analysis of Optimal Conditions in Fquilibrium Imaging of in Vivo Receptors , 1985, IEEE Transactions on Nuclear Science.

[20]  J. Barrio,et al.  Nonlinearity in Modeling Receptor-Binding Ligands , 1987 .

[21]  J B Bassingthwaighte,et al.  Sensitivity functions in the estimation of parameters of cellular exchange. , 1984, Federation proceedings.

[22]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[23]  C. D. Arnett,et al.  Comparison of Three 18F‐Labeled Butyrophenone Neuroleptic Drugs in the Baboon Using Positron Emission Tomography , 1985, Journal of neurochemistry.

[24]  K. B. Larson,et al.  Strategies for in vivo Measurement of Receptor Binding Using Positron Emission Tomography , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  B. Zeeberg,et al.  Elevated D2 dopamine receptors in drug-naïve schizophrenics. , 1988, Science.

[26]  M. Raichle,et al.  Preliminary studies with [18F]haloperidol: a radioligand for in vivo studies of the dopamine receptors , 1980, Brain Research.

[27]  J S Fowler,et al.  Kinetic Modeling of Receptor‐Ligand Binding Applied to Positron Emission Tomographic Studies with Neuroleptic Tracers , 1987, Journal of neurochemistry.

[28]  J. Fields,et al.  3H-Spiroperidol binding to two receptor sites in both the corpus striatum and frontal cortex of rat brain. , 1978, European journal of pharmacology.

[29]  A. Gjedde,et al.  Quantification of Neuroreceptors in the Living Human Brain. I. Irreversible Binding of Ligands , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  P. Seeman Brain dopamine receptors. , 1980, Pharmacological reviews.

[31]  G T Gullberg,et al.  Quantitative potentials of dynamic emission computed tomography. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.